ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

GRCL Gracell Biotechnologies Inc

10.25
0.00 (0.00%)
10 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Gracell Biotechnologies Inc GRCL 나스닥 주식예탁증서 (DR)
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.00 0.00% 10.25 09:00:00
개장가 저가 고가 종가 전일 종가
10.25 10.25
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
05/03/202402:22EDGAR2Form 15-12G - Securities registration termination [Section..
28/02/202414:15EDGAR2Form EFFECT - Notice of Effectiveness
27/02/202407:28EDGAR2Form S-8 POS - Securities to be offered to employees in..
27/02/202407:28EDGAR2Form POS AM - Post-Effective amendments for registration..
27/02/202407:26EDGAR2Form POS AM - Post-Effective amendments for registration..
27/02/202407:26EDGAR2Form S-8 POS - Securities to be offered to employees in..
22/02/202422:50EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
22/02/202422:45GLOBEGracell Biotechnologies Acquisition Completed
20/02/202422:22EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/02/202421:45GLOBEGracell Biotechnologies Announces Shareholders’ Approval of..
14/02/202422:20EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
30/01/202420:02EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
29/01/202421:00GLOBEGracell Biotechnologies Announces FDA Clearance of IND..
18/01/202406:30EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/01/202406:01EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
09/01/202400:06PRNUSKuehn Law Encourages KRTX, DSKE, RYZB, and GRCL Investors to..
26/12/202322:12EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
26/12/202320:44DJNGracell ADSs Take Flight Premarket on $1.2 Billion Takeover..
26/12/202317:05DJNAstraZeneca to Buy Gracell Biotechnologies for $1.2 Billion
26/12/202316:01BWAstraZeneca to acquire Gracell, furthering cell therapy..
26/12/202316:00GLOBEGracell Biotechnologies to be acquired by AstraZeneca,..
22/12/202320:03EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
21/12/202321:00GLOBEGracell Biotechnologies Announces China NMPA Clearance for..
19/12/202306:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/12/202309:30GLOBEGracell Biotechnologies Presents Updated Clinical Data from..
29/11/202320:18IHMARKETNEWSAmazon Unveils Innovative Services, Okta Discloses Data..
29/11/202304:59DJNCabaletta Bio Down as FDA Looks Into Issues With Several..
27/11/202322:00GLOBEGracell Biotechnologies Announces FDA Clearance of IND..
21/11/202320:25EDGAR2Form 144 - Report of proposed sale of securities
16/11/202322:00GLOBEGracell Biotechnologies to Participate in Inaugural Cell..
14/11/202320:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
13/11/202321:30GLOBEGracell Biotechnologies Reports Third Quarter 2023 Unaudited..
08/11/202322:30GLOBEGracell Biotechnologies Wins Overall Immunology Solution of..
02/11/202322:00GLOBEGracell Biotechnologies to Present Updated Results from..
02/11/202305:00GLOBEGracell Biotechnologies to Participate in Four Upcoming..
31/10/202322:00GLOBEGracell Biotechnologies to Present Data Highlighting..
30/10/202321:30GLOBEGracell Biotechnologies to Report Third Quarter 2023..
29/09/202319:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/09/202321:30GLOBEGracell Biotechnologies Reports Updated Clinical Data for..
27/09/202319:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/09/202305:00GLOBEGracell Biotechnologies Doses First Patient in Phase 1b/2..
19/09/202322:21GLOBEGracell Biotechnologies’ CEO Dr. William Cao Named to..
14/09/202322:15GLOBEGracell Biotechnologies to Participate in Three Upcoming..
13/09/202305:12EDGAR2Form F-3/A - Registration statement by foreign private..
06/09/202321:00PRNUSGracell Biotechnologies to Present Updated Clinical Data on..
25/08/202305:10GLOBEGracell Biotechnologies to Participate in Two Upcoming..
25/08/202305:03EDGAR2Form F-3 - Registration statement by foreign private issuers
23/08/202319:47EDGAR2Form 144 - Report of proposed sale of securities
19/08/202305:56EDGAR2Form SC 13G - Statement of acquisition of beneficial..
15/08/202305:52EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

최근 히스토리

Delayed Upgrade Clock